Symbols / ZIVO $3.25 -13.33% ZIVO Bioscience, Inc.

Healthcare • Biotechnology • United States • OID
ZIVO Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index —
Sector Healthcare
Industry Biotechnology
CEO —
Exch · Country OID · United States
Market Cap 14.58M
Enterprise Value —
Income —
Sales —
FCF (ttm) -2.62M
Book/sh —
Cash/sh —
Employees —
Insider 10d —
IPO —
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout —
P/E —
Forward P/E —
PEG —
P/S —
P/B —
P/C —
EV/EBITDA —
EV/Sales —
Quick Ratio —
Current Ratio —
Debt/Eq —
LT Debt/Eq —
EPS (ttm) -2.18
EPS next Y —
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) —
Earnings (prior) —
ROA —
ROE —
ROIC —
Gross Margin —
Oper. Margin —
Profit Margin —
Shs Outstand 3.89M
Shs Float —
Insider Own —
Instit Own —
Short Float —
Short Ratio —
Short Interest —
52W High —
vs 52W High —
52W Low —
vs 52W Low —
Beta —
Impl. Vol. —
Rel Volume —
Avg Volume —
Volume —
Target (mean) —
Tgt Median —
Tgt Low —
Tgt High —
# Analysts —
Recom —
Prev Close $3.75
Price $3.25
Change -13.33%
About

ZIVO Bioscience, Inc., together with its subsidiaries, engages in licensing and selling natural bioactive ingredients derived from its proprietary algae cultures to animal, human, and dietary supplement and medical food manufacturers. The company operates in the biotech and agtech sectors, with an intellectual property portfolio comprising proprietary algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques, and patented or patent-pending inventions for applications in human and animal health. It offers poultry gut health, avian influenza, bovine mastitis, canine joint health, human immune modification, human functional food ingredients, algal biomass for human food, and biomass for supporting skin health and anti-aging. The company was formerly known as Health Enhancement Products, Inc. and changed its name to ZIVO Bioscience, Inc. in October 2014. ZIVO Bioscience, Inc. is headquartered in Troy, Michigan.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$3.25
Latest analyst target
3. DCF / Fair value
$-12.12
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$3.25
Low
—
High
—
Mean
—

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2024-06-04 down Maxim Group Buy → Hold —
News
RSS: Latest ZIVO news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
0.16
+468.61%
0.03
0.00
0.00
Operating Revenue
0.16
+468.61%
0.03
0.00
0.00
Cost Of Revenue
0.11
+574.99%
0.02
0.00
—
Reconciled Cost Of Revenue
0.11
+574.99%
0.02
0.00
—
Gross Profit
0.05
+321.64%
0.01
0.00
—
Operating Expense
13.41
+84.35%
7.27
-16.69%
8.73
+1.00%
8.65
Research And Development
3.13
+127.66%
1.38
-38.53%
2.24
+14.86%
1.95
Selling General And Administration
10.28
+74.24%
5.90
-9.15%
6.49
-3.03%
6.69
General And Administrative Expense
10.28
+74.24%
5.90
-9.15%
6.49
-3.03%
6.69
Other Gand A
10.28
+74.24%
5.90
-9.15%
6.49
-3.03%
6.69
Total Expenses
13.52
+85.43%
7.29
-16.51%
8.73
+1.00%
8.65
Operating Income
-13.36
-83.97%
-7.26
+16.82%
-8.73
-1.00%
-8.65
Total Operating Income As Reported
-13.36
-83.97%
-7.26
+16.82%
-8.73
-1.00%
-8.65
EBITDA
-13.36
-83.97%
-7.26
+16.82%
-8.73
-2.46%
-8.52
Normalized EBITDA
-13.36
-83.97%
-7.26
+16.82%
-8.73
-1.00%
-8.65
EBIT
-13.36
-83.97%
-7.26
+16.82%
-8.73
-2.46%
-8.52
Total Unusual Items
—
—
0.00
-100.00%
0.12
Total Unusual Items Excluding Goodwill
—
—
0.00
-100.00%
0.12
Special Income Charges
—
—
0.00
-100.00%
0.12
Other Special Charges
—
—
—
-0.12
Net Income
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Pretax Income
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Net Non Operating Interest Income Expense
-0.02
+95.54%
-0.51
-3760.44%
-0.01
+94.29%
-0.23
Interest Expense Non Operating
0.02
-95.54%
0.51
+3760.44%
0.01
-94.29%
0.23
Net Interest Income
-0.02
+95.54%
-0.51
-3760.44%
-0.01
+94.29%
-0.23
Interest Expense
0.02
-95.54%
0.51
+3760.44%
0.01
-94.29%
0.23
Other Income Expense
—
—
—
0.12
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Net Income From Continuing Operation Net Minority Interest
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Net Income From Continuing And Discontinued Operation
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Net Income Continuous Operations
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Normalized Income
-13.38
-72.10%
-7.78
+11.07%
-8.75
+1.50%
-8.88
Net Income Common Stockholders
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Diluted EPS
-4.23
+8.04%
-4.60
+17.41%
-5.57
+19.28%
-6.90
Basic EPS
-4.23
+8.04%
-4.60
+17.41%
-5.57
+19.28%
-6.90
Basic Average Shares
3.17
+87.40%
1.69
+7.65%
1.57
+23.47%
1.27
Diluted Average Shares
3.17
+87.40%
1.69
+7.65%
1.57
+23.47%
1.27
Diluted NI Availto Com Stockholders
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
1.64
+195.68%
0.56
-73.82%
2.12
-76.39%
8.99
Current Assets
1.64
+284.47%
0.43
-77.63%
1.90
-78.78%
8.96
Cash Cash Equivalents And Short Term Investments
1.54
+462.16%
0.27
-84.75%
1.80
-79.79%
8.90
Cash And Cash Equivalents
1.54
+462.16%
0.27
-84.75%
1.80
-79.79%
8.90
Cash Financial
1.54
+462.16%
0.27
-84.75%
1.80
-79.79%
8.90
Receivables
0.00
-40.80%
0.00
0.00
—
Accounts Receivable
0.00
-40.80%
0.00
0.00
—
Gross Accounts Receivable
—
0.00
0.00
—
Prepaid Assets
0.09
-38.35%
0.15
+43.79%
0.10
+76.34%
0.06
Total Non Current Assets
0.01
-94.11%
0.13
-41.11%
0.22
+632.31%
0.03
Net PPE
0.00
-100.00%
0.10
-48.08%
0.19
+595.25%
0.03
Gross PPE
0.00
-100.00%
0.10
-48.08%
0.19
+595.25%
0.03
Accumulated Depreciation
—
—
—
-0.10
Machinery Furniture Equipment
—
—
—
0.02
Other Properties
—
0.10
-48.08%
0.19
+595.25%
0.03
Non Current Prepaid Assets
0.01
-76.04%
0.03
+0.00%
0.03
+968.60%
0.00
Total Liabilities Net Minority Interest
2.16
-21.86%
2.76
+29.43%
2.13
-27.62%
2.95
Current Liabilities
2.04
-26.06%
2.76
+36.19%
2.03
-31.22%
2.95
Payables And Accrued Expenses
0.81
-36.24%
1.27
+115.03%
0.59
-21.50%
0.75
Payables
0.74
-36.36%
1.17
+137.59%
0.49
-25.01%
0.65
Accounts Payable
0.55
-44.91%
0.99
+102.39%
0.49
-25.01%
0.65
Current Accrued Expenses
0.07
-34.82%
0.10
+2.44%
0.10
+2.50%
0.10
Pensionand Other Post Retirement Benefit Plans Current
1.10
-4.58%
1.15
+188.51%
0.40
-14.78%
0.47
Current Debt And Capital Lease Obligation
0.14
-60.11%
0.35
+2.09%
0.34
+32.95%
0.26
Current Debt
0.14
-42.43%
0.24
+0.00%
0.24
+0.00%
0.24
Other Current Borrowings
0.14
-42.43%
0.24
+0.00%
0.24
+0.00%
0.24
Current Capital Lease Obligation
0.00
-100.00%
0.11
+7.14%
0.10
+553.97%
0.02
Current Deferred Liabilities
—
0.00
-100.00%
0.70
-52.46%
1.48
Total Non Current Liabilities Net Minority Interest
0.12
0.00
-100.00%
0.11
0.00
Long Term Debt And Capital Lease Obligation
0.12
0.00
-100.00%
0.11
0.00
Long Term Debt
0.12
—
—
—
Long Term Capital Lease Obligation
—
0.00
-100.00%
0.11
0.00
Stockholders Equity
-0.51
+76.66%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Common Stock Equity
-0.51
+76.66%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Capital Stock
0.00
+51.95%
0.00
+51.78%
0.00
-83.33%
0.01
Common Stock
0.00
+51.95%
0.00
+51.78%
0.00
-83.33%
0.01
Share Issued
3.62
+52.01%
2.38
+51.75%
1.57
+0.00%
1.57
Ordinary Shares Number
3.62
+52.01%
2.38
+51.75%
1.57
+0.00%
1.57
Additional Paid In Capital
136.45
+12.42%
121.37
+4.82%
115.79
+2.39%
113.09
Retained Earnings
-136.97
-10.83%
-123.58
-6.72%
-115.80
-8.17%
-107.06
Total Equity Gross Minority Interest
-0.51
+76.66%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Total Capitalization
-0.40
+81.93%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Working Capital
-0.41
+82.60%
-2.34
-1753.48%
-0.13
-102.10%
6.01
Invested Capital
-0.26
+86.75%
-1.97
-957.03%
0.23
-96.35%
6.28
Total Debt
0.25
-26.56%
0.35
-22.20%
0.45
+74.46%
0.26
Capital Lease Obligations
0.00
-100.00%
0.11
-48.17%
0.21
+1251.81%
0.02
Net Tangible Assets
-0.51
+76.66%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Tangible Book Value
-0.51
+76.66%
-2.21
-20666.74%
-0.01
-100.18%
6.04
Dueto Related Parties Current
0.19
+12.79%
0.17
0.00
—
Interest Payable
0.07
-34.82%
0.10
+2.44%
0.10
+2.50%
0.10
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-4.31
+25.63%
-5.80
+18.34%
-7.10
-4.40%
-6.80
Cash Flow From Continuing Operating Activities
-4.31
+25.63%
-5.80
+18.34%
-7.10
-4.40%
-6.80
Net Income From Continuing Operations
-13.38
-72.10%
-7.78
+11.07%
-8.75
+0.12%
-8.76
Other Non Cash Items
0.10
+157.56%
-0.17
+75.41%
-0.69
-38.65%
-0.50
Stock Based Compensation
9.47
+992.23%
0.87
-67.79%
2.69
-9.35%
2.97
Operating Gains Losses
—
—
—
-0.12
Gain Loss On Investment Securities
—
—
—
0.03
Change In Working Capital
-0.50
-139.08%
1.28
+460.35%
-0.36
+9.83%
-0.39
Change In Receivables
0.00
+140.80%
-0.00
0.00
—
Changes In Account Receivables
0.00
+140.80%
-0.00
0.00
—
Change In Prepaid Assets
0.08
+280.29%
-0.04
+38.90%
-0.07
-160.96%
-0.03
Change In Payables And Accrued Expense
-0.48
-133.37%
1.43
+720.09%
-0.23
+45.44%
-0.42
Change In Accrued Expense
-0.05
-106.98%
0.75
+1229.96%
-0.07
-113.79%
0.48
Change In Payable
-0.42
-162.79%
0.68
+512.49%
-0.16
+81.92%
-0.91
Change In Account Payable
-0.42
-162.79%
0.68
+512.49%
-0.16
+81.92%
-0.91
Change In Other Working Capital
—
—
—
0.09
Change In Other Current Liabilities
-0.11
-7.60%
-0.10
-91.19%
-0.05
-77.21%
-0.03
Investing Cash Flow
0.00
0.00
0.00
0.00
Financing Cash Flow
5.58
+30.56%
4.28
0.00
-100.00%
15.57
Cash Flow From Continuing Financing Activities
5.58
+30.56%
4.28
0.00
-100.00%
15.57
Net Issuance Payments Of Debt
-0.02
0.00
0.00
0.00
Issuance Of Debt
0.52
-70.52%
1.76
+179.29%
0.63
+229.97%
0.19
Repayment Of Debt
-0.54
+69.34%
-1.76
-179.29%
-0.63
-229.97%
-0.19
Long Term Debt Issuance
0.52
-70.52%
1.76
+179.29%
0.63
+229.97%
0.19
Long Term Debt Payments
-0.54
+69.34%
-1.76
-179.29%
-0.63
-229.97%
-0.19
Net Long Term Debt Issuance
-0.02
0.00
0.00
0.00
Short Term Debt Issuance
—
1.76
+179.29%
0.63
—
Short Term Debt Payments
—
-1.76
-179.29%
-0.63
—
Net Short Term Debt Issuance
—
0.00
0.00
—
Net Common Stock Issuance
5.60
+775.35%
0.64
0.00
-100.00%
17.21
Proceeds From Stock Option Exercised
0.00
-100.00%
3.64
0.00
-100.00%
0.06
Net Other Financing Charges
—
—
—
-1.70
Changes In Cash
1.27
+183.16%
-1.52
+78.53%
-7.10
-181.04%
8.76
Beginning Cash Position
0.27
-84.75%
1.80
-79.79%
8.90
+6357.09%
0.14
End Cash Position
1.54
+462.16%
0.27
-84.75%
1.80
-79.79%
8.90
Free Cash Flow
-4.31
+25.63%
-5.80
+18.34%
-7.10
-4.40%
-6.80
Interest Paid Supplemental Data
0.02
-73.74%
0.07
+560.97%
0.01
+254.09%
0.00
Income Tax Paid Supplemental Data
0.00
0.00
0.00
0.00
Common Stock Issuance
5.60
+775.35%
0.64
0.00
-100.00%
17.21
Issuance Of Capital Stock
5.60
+775.35%
0.64
0.00
-100.00%
17.21
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category